[Main therapeutic advances in IBD in 2008].
A coimmunosuppression with azathioprine or methotrexate in addition to infliximab does not improve the therapeutic efficacy in Crohn's disease but increase the risks of infectious complications and neoplasia.
Felley
C
C
Service de gastroentérologie et d'hépatologie, CHUV, Lausanne.
Mottet
C
C
Hess
J
J
Maillard
M H
MH
Delarive
J
J
Michetti
P
P
D018890:Chemoprevention; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000628:therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D005765:Gastrointestinal Agents; D014409:Tumor Necrosis Factor-alpha